• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gennex Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Prudential
  • BSE Code : 14707.0
  • ISIN : INE509C01026
10.82 1 (13.30%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    9.55

  • Today’s High

    11.00

  • Open

    9.55

  • Perv Close

    9.55

  • 52W Low

    7.05

  • 52W High

    17.25

Key Indicators

  • P/E(TTM)

    15.68

  • Mar.Cap (₹Cr.)

    262.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.98

  • Debt-Equity Ratio

    13.30

  • AGM Date

    14-Aug-2026

  • EPS

    0.69

  • P/E Ratio

    15.68

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    262.87

  • RONW (%)

    10.51

  • ROCE (%)

    13.64

Score Board

  • Equity (₹ in Cr.)

    24.29

  • BV (₹)

    9.00

  • Sales( ₹ in Cr.)

    119.86

  • NP (in Cr.)

    16.66

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    262.87

  • 52 Week High

    17.25

  • 52 Week Low

    7.05

  • Price BSE

    11.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    262.87

  • P/C Ratio

    15.20

  • P/E Ratio

    16.00

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 105.11 74.05 71.35 65.26 63.65 59.96
Excise Duty 10.53 7.25 6.25 4.05 4.00 4.34
Net Sales 94.58 66.80 65.10 61.21 59.65 55.62
Other Income 9.22 4.30 3.40 1.38 0.52 1.06
Stock Adjustments 0.70 2.44 7.00 1.91 -1.53 1.51
Total Income 104.50 73.54 75.50 64.50 58.64 58.19
EXPENDITURE :            
Raw Materials 68.36 41.94 48.14 41.23 35.18 36.20
Power and Fuel Cost 3.08 3.29 4.26 3.17 3.01 3.30
Employee Cost 6.42 6.05 7.71 6.97 7.21 6.81
Other Manufacturing Expenses 0.77 1.06 1.18 0.80 2.14 3.67
Selling and Administration Expenses 4.72 2.93 4.40 3.43 3.44 3.34
Miscellaneous Expenses 1.74 1.54 1.82 2.15 0.98 0.56
Employee Benefit Expenses 6.42 6.05 7.71 6.97 7.21 6.81
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 85.08 56.81 67.51 57.74 51.96 53.88
Operating Profit 19.41 16.73 7.99 6.76 6.68 4.30
Interest 1.58 1.16 1.23 0.88 0.74 0.75
Gross Profit 17.83 15.57 6.76 5.88 5.94 3.55
Depreciation 0.77 0.81 0.74 0.79 0.88 1.00
Profit Before Tax 17.06 14.76 6.02 5.09 5.06 2.55
Current Tax 2.97 3.05 1.59 1.32 1.27 0.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.09 -0.14 -0.15 -0.25 -0.16
Reported Net Profit 14.04 11.80 4.56 3.92 4.04 1.86
Extraordinary Items -0.14 0.00 0.04 0.00 -0.28 0.08
Adjusted Net Profit 14.18 11.80 4.52 3.92 4.32 1.78
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 40.02 28.22 23.66 19.74 15.70 13.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 54.05 40.02 28.22 23.66 19.74 15.70
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.62 0.52 0.25 0.31 0.32 0.15
Earnings Per Share(Adj)-Unit Curr 0.62 0.52 0.25 0.30 0.31 0.14
Book Value 7.87 7.26 4.39 3.48 3.15 2.83
Book Value(Adj)-Unit Curr 7.87 7.26 4.39 3.32 3.00 2.69

Shareholding Pattern

  • Promoter Group

    23.63%

  • Public Share Holding

    76.37%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 56,591,874 23.29 56,591,874 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 48,300 0.02 48,300 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 765,450 0.32 765,450 1
Others 0 0.00 0 0
Sub Total 57,405,624 23.63 57,405,624 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 3,600 0.00 3,600 1
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,600 0.00 3,600 1
2] Non Institution
Bodies Corporate 34,736,545 14.30 34,734,545 232
Clearing Members 0 0.00 0 0
Directors of their Relatives 113,041 0.05 113,041 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,826,339 2.81 6,826,339 724
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 36,537,810 15.04 36,537,810 72
Individuals holding nominal share capital up to Rs. 1 lakh 100,693,778 41.45 98,674,448 81,786
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 500 0.00 500 1
Others 462,000 0.19 462,000 3
Sub Total 185,538,450 76.37 183,517,120 82,876
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 242,947,674 100.00 240,926,344 82,886

Company Background

Gennex Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Gennex Laboratories Ltd
  • BSE Code : 14707.0
  • ISIN : INE509C01026

  • Incorporation Year

    1990

  • Registered Office

    Survey No 133 Bollaram
    Jinnaram Mandal, Medak,
    Telangana-502325

  • Telephone

    91-8458-279406/279516

  • FAX

  • Chairman

    Arihant Baid

  • Managing Director

  • Company Secretary

    DINESH KUMAR KEJRIWAL

  • Auditor

    R Pugalia & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    R & D Infotech Pvt Ltd
    7A Betala Road,
    1st Floor,
    Mumbai - Kolkata - 700 026

Gennex Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gennex Lab. 10.82 103.80 105.11 16.39 10.25
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77